John A. Jenkins

Articles by this author

Big Safety Questions About India’s Pharma

FOIAengine Reveals Media Pushing FDA for Answers Journalists made an unusually high number of requests last month to the Food and Drug Administration for information about the safety of India’s...

Bloomberg’s “FOIA Terrorist”

FOIAengine Reveals a Savvy Journalist’s Big Impact Bloomberg’s 320,000 terminals are life blood to Wall Street traders.  The company, with 20,000 employees in 176 offices, derives an estimated 90 percent...

More Litigation as Whistleblowers Lawyer Up

FOIAengine: Fights Erupt as SEC’s Tipsters Seek to Cash In After the Securities and Exchange Commission awarded $279 million last month to an anonymous whistleblower, a flurry of Freedom of Information...

Whistleblower, or Opportunist? A Short Seller Helps the Government

FOIAengine Reveals the Litigious Path to a Big SEC Payout Carson Block is a buccaneering stock trader, reveling in a role that’s long on risk and short on sympathy.  He’s...

Hedge Funds Target Big Pharma

FOIAengine: Requests to FDA Reveal What the Funds Are Watching New data reveals that big hedge funds were unusually active in making information requests about pharmaceutical companies to the Food and...

Foreign Bribery Investigations Loom for Pfizer

FOIAengine Uncovers a Persistent Questioner. What Does He Know? Albert Bourla earns $33 million a year as the CEO of Pfizer, the world’s largest pharmaceutical company.  His improbable journey to the top began in...